Expertise in
6
conditions

Jean-philippe P. Camdessanche

Saint-etienne-de-valoux, FR 
Expertise in
6
conditions
Saint-etienne-de-valoux, FR 

Overview

Jean-philippe Camdessanche practices practicing medicine in Saint-etienne-de-valoux, France.

Camdessanche is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Multiple Sclerosis (MS), Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Relapsing Multiple Sclerosis (RMS).

They are actively involved in clinical research, co-authoring 136 peer reviewed articles and participating in 7 clinical trials.

Locations

Saint-etienne-de-valoux, 42055, France
Other Locations
Saint Étienne, France
Saint-claude-de-diray, France
Lyon, 69000, France
St Priest En Jarez, Sete, France
Paris, France
10 Rue De Marandière, Saint-priest-la-vetre, 42270, France
Bron, France
Loire, France
Nantes, France
CHU St Etienne, Saint-etienne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Enrollment Status: Terminated
Publish Date: February 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
Validation Study of the French Adaptation of the MSWDQ-23 Questionnaire, a Tool Assessing the Work Difficulties of Patients With Multiple Sclerosis.
Validation Study of the French Adaptation of the MSWDQ-23 Questionnaire, a Tool Assessing the Work Difficulties of Patients With Multiple Sclerosis.
Enrollment Status: Completed
Publish Date: February 05, 2024
Intervention Type: Other
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological, Drug, Other
Study Drugs: Vitamin D, Lumbar Puncture, Blood Sampling, Urine Samples
Study Phase: Phase 3
Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients
Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Other
Study Phase: Not Applicable
Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?
Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Device, Biological, Other
Study Drug: Blood Sample
Study Phase: Phase 2
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Other
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis : Impact and Prognosis. Single-center Prospective Pilot Study
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis : Impact and Prognosis. Single-center Prospective Pilot Study
Enrollment Status: Terminated
Publish Date: January 05, 2021
Intervention Type: Other
View 6 Less Clinical Trials

136 Total Publications

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).
Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: August 04, 2026

Frequently Asked Questions about Jean-philippe P. Camdessanche

Is Jean-philippe P. Camdessanche a top-rated expert for Multiple Sclerosis (MS)?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-philippe P. Camdessanche is classified as an Advanced expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-philippe P. Camdessanche participate in research or clinical trials?

Yes. Jean-philippe P. Camdessanche has published 136 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Jean-philippe P. Camdessanche's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Camdessanche's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile